Characterisation of Limosilactobacillus reuteri BG-R33®, an evolved aerotolerant derivative of the probiotic strain ATCC PTA 5289
Journal of Industrial Microbiology and Biotechnology · 17.11.2026
DOI: 10.1093/jimb/kuag030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Industrial Microbiology and Biotechnology, online erschienen am 17.11.2026. Verfasst von Malin Sendelius und 7 weiteren Autor:innen. Beteiligte Einrichtung: BioGaia AB, SE- 103 64 Stockholm, Sweden. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Probiotic strains intended for use in the oral cavity and upper respiratory tract are exposed to substantially higher oxygen levels than strains targeting the intestinal environment. We hypothesised that continuous oxygen exposure of an established probiotic strain used under conditions of high oxidative pressure, namely Limosilactobacillus reuteri ATCC PTA 5289 (Lr5289), would enable the natural selection of a variant better adapted to such an environment. Using this approach, the novel strain L. reuteri BG-R33® (DSM 33633) was obtained and demonstrated improved tolerance to an oxygen-rich environment. Interestingly, the strain also exhibited increased tolerance to hydrogen peroxide, a frequent challenge in the oral environment. In addition, compared to its progenitor, the novel strain showed a slightly improved capacity to inhibit the oral pathogen Streptococcus mutans and enterotoxigenic Escherichia coli, mainly through production of the antimicrobial metabolite reuterin. Tolerance to gastrointestinal stressors was also evaluated, and BG-R33® displayed increased bile tolerance compared with Lr5289, whereas tolerance to low pH (2.0) and adhesion to mucus and saliva did not differ between the strains. Both the genotype and phenotype of the novel strain were shown to be stable. Finally, BG-R33® was characterised in direct comparison with Lr5289 and exhibited a similar genomic and phenotypic safety profile, with no concerns identified. These subtle but distinct differences between the strains provide a rationale for further investigation of L. reuteri BG-R33® for applications targeting disorders of the oral cavity and upper respiratory tract.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BioGaia AB, SE- 103 64 Stockholm, Sweden.
- Department of Molecular Sciences, Uppsala BioCenter, Swedish University of Agricultural Sciences, 750 07 Uppsala, Sweden.
- Division of Biotechnology and Applied Microbiology, Lund University, 221 00 Lund, Sweden.
- Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 413 45 Gothenburg, Sweden.
ORCID-Profile: Malin Sendelius, Ludwig Ermann Lundberg, Punya Pallabi Mishra, Peidi Liu, Sebastian Håkansson, Jakob Axelsson, Gianfranco Grompone, Stefan Roos
Zitieren
APA
Sendelius, M., Lundberg, L. E., Mishra, P. P., Liu, P., Håkansson, S., Axelsson, J., Grompone, G., & Roos, S. (2026). Characterisation of Limosilactobacillus reuteri BG-R33®, an evolved aerotolerant derivative of the probiotic strain ATCC PTA 5289. Journal of Industrial Microbiology and Biotechnology. https://doi.org/10.1093/jimb/kuag030
Vancouver
Sendelius M, Lundberg LE, Mishra PP, Liu P, Håkansson S, Axelsson J, et al. Characterisation of Limosilactobacillus reuteri BG-R33®, an evolved aerotolerant derivative of the probiotic strain ATCC PTA 5289. Journal of Industrial Microbiology and Biotechnology. 2026. doi:10.1093/jimb/kuag030
BibTeX
@article{Sendelius2026,
author = {Sendelius, Malin and Lundberg, Ludwig Ermann and Mishra, Punya Pallabi and Liu, Peidi and Håkansson, Sebastian and Axelsson, Jakob and Grompone, Gianfranco and Roos, Stefan},
title = {Characterisation of Limosilactobacillus reuteri BG-R33®, an evolved aerotolerant derivative of the probiotic strain ATCC PTA 5289},
journal = {Journal of Industrial Microbiology and Biotechnology},
year = {2026},
doi = {10.1093/jimb/kuag030}
}
EUVIMED